Otrivin Ukonserveret (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Otrivin Ukonserveret, is a topical nasal decongestant presented as a nasal spray solution for intranasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Otrivin Ukonserveret as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride acts on the nasal mucosa to produce vasoconstriction, providing relief in upper‑respiratory congestion.

- Common cold: reduces nasal blockage and improves airflow - Allergic rhinitis: alleviates congestion caused by allergen exposure - Sinusitis: eases sinus pressure by decongesting nasal passages

Adverse reactions are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Nasal burning or stinging sensation - Dryness of the nasal passages - Headache - Transient taste disturbance

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) with prolonged use - Severe hypertension or hypertensive crisis - Allergic reactions such as angioedema or urticaria

Use of Xylometazoline nasal spray requires attention to several safety considerations.

- Age restriction: avoid use in children under 6 years unless advised by a clinician - Duration: limit treatment to 3–5 days to prevent rebound congestion - Cardiovascular disease: use with caution in patients with hypertension or heart disease - Pregnancy and lactation: consult a healthcare professional before use - Drug interactions: avoid concomitant use with monoamine oxidase inhibitors - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight

Xylometazoline may interact with other sympathomimetic agents and cardiovascular drugs.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis - Oral decongestants (e.g., pseudoephedrine): additive vasoconstriction may raise blood pressure - Beta‑blockers: may enhance blood‑pressure effects

Moderate Interactions (Monitor Closely):\n- Antihypertensive agents: possible reduction in antihypertensive efficacy - Tricyclic antidepressants: additive cardiovascular stimulation - Other nasal sprays (e.g., steroids): monitor for increased local irritation